Cargando…
Endocrine therapy initiation, discontinuation and adherence and breast imaging among 21-gene recurrence score assay-eligible women under age 65
BACKGROUND: Aside from chemotherapy utilization, limited data are available on the relationship between gene expression profiling (GEP) testing and breast cancer care. We assessed the relationship between GEP testing and additional variables and the outcomes of endocrine therapy initiation, disconti...
Autores principales: | O’Neill, Suzanne C., Isaacs, Claudine, Lynce, Filipa, Graham, Deena Mary Atieh, Chao, Calvin, Sheppard, Vanessa B., Zhou, Yingjun, Liu, Chunfu, Selvam, Nandini, Schwartz, Marc D., Potosky, Arnold L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5374604/ https://www.ncbi.nlm.nih.gov/pubmed/28359319 http://dx.doi.org/10.1186/s13058-017-0837-2 |
Ejemplares similares
-
Association between Medicare eligibility at age 65 years and in-hospital treatment patterns and health outcomes for patients with trauma: regression discontinuity approach
por: Bhaumik, Deepon, et al.
Publicado: (2023) -
Patient Eligibility for Transoral Endocrine Surgery Procedures in the United States
por: Grogan, Raymon H., et al.
Publicado: (2019) -
Tyrosine Kinase Inhibitor discontinuation in Chronic Myeloid Leukemia: eligibility criteria and predictors of success
por: Inzoli, Elena, et al.
Publicado: (2022) -
Endocrine Therapy Nonadherence and Discontinuation in Black and White Women
por: Wheeler, Stephanie B, et al.
Publicado: (2018) -
HALT-D: a randomized open-label phase II study of crofelemer for the prevention of chemotherapy-induced diarrhea in patients with HER2-positive breast cancer receiving trastuzumab, pertuzumab, and a taxane
por: Pohlmann, Paula R., et al.
Publicado: (2022)